Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Nan You

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5018389396. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Clinical Efficacy of Tislelizumab Plus Gemcitabine-Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer and Chemoresistance Analysis: A Prospective Pilot… Co-author DOI 10.1245/s10434-026-20711-3↗
  2. Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. Co-author DOI 10.3389/fonc.2023.1167144↗
  3. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mc.22520↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lu Zheng · 1 shared paper, 2026 · strength 0.28
  2. Yonggang He · 1 shared paper, 2026 · strength 0.28
  3. Lu Zheng · 2 shared papers, 2017–2023 · strength 0.24
  4. Xiaobing Huang · 2 shared papers, 2017–2023 · strength 0.24
  5. Yichen Tang · 1 shared paper, 2023 · strength 0.17
  6. Yonggang He · 1 shared paper, 2023 · strength 0.17
  7. Liang Wang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.